Literature DB >> 7927703

Genetic map of the Actinobacillus pleuropneumoniae RTX-toxin (Apx) operons: characterization of the ApxIII operons.

R Jansen1, J Briaire, A B van Geel, E M Kamp, A L Gielkens, M A Smits.   

Abstract

Actinobacillus pleuropneumoniae RTX-toxin III (ApxIII) is implicated as an important virulence factor of A. pleuropneumoniae, the causative agent of porcine pleuropneumonia. Recently, the genes coding for ApxIII (apxIIICA) of serotype 8 were cloned and characterized. The toxin appeared to be a member of the RTX-toxin family, as are the other two secreted toxins of A. pleuropneumoniae, i.e., ApxI and ApxII. In this report, we describe the cloning and sequencing of the remaining part of the ApxIII operon of serotype 8. This sequence coded for the RTX secretion proteins ApxIIIB and ApxIIID, which showed 86 and 63% similarity to ApxIB and ApxID, respectively, and 83 and 63% similarity to HlyB and HlyD of Escherichia coli, respectively. Potential functional domains, such as eight transmembrane regions and an ATP-binding cassette, were present in ApxIIIB. We examined the presence of apxIIICABD sequences in the 12 serotypes of A. pleuropneumoniae and found that these sequences were present only in serotypes 2, 3, 4, 6, and 8, the serotypes that secrete ApxIII. Comparison of the apxIIICABD gene sequences of the serotypes revealed very few serotype-specific differences. Only the C terminus of ApxIIIA of serotype 2 differed from ApxIIIA of the other serotypes. The differences were located between the glycine-rich repeats and the secretion signal. The analysis of the apxIIICABD genes completed our efforts to characterize the ApxI, ApxII, and ApxIII operons of the reference strains of the 12 serotypes of A. pleuropneumoniae. We present a complete map of the ApxI, ApxII, and ApxIII operons and discuss this in terms of gene expression and complementation and the role of the toxins in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927703      PMCID: PMC303124          DOI: 10.1128/iai.62.10.4411-4418.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  ABC transporters: from microorganisms to man.

Authors:  C F Higgins
Journal:  Annu Rev Cell Biol       Date:  1992

2.  Topological and functional studies on HlyB of Escherichia coli.

Authors:  I Gentschev; W Goebel
Journal:  Mol Gen Genet       Date:  1992-03

Review 3.  Virulence properties of Actinobacillus pleuropneumoniae.

Authors:  T J Inzana
Journal:  Microb Pathog       Date:  1991-11       Impact factor: 3.738

4.  Mutational analysis supports a role for multiple structural features in the C-terminal secretion signal of Escherichia coli haemolysin.

Authors:  P Stanley; V Koronakis; C Hughes
Journal:  Mol Microbiol       Date:  1991-10       Impact factor: 3.501

Review 5.  ABC transporters: bacterial exporters.

Authors:  M J Fath; R Kolter
Journal:  Microbiol Rev       Date:  1993-12

6.  Experimental reproduction of acute lesions of porcine pleuropneumonia with a haemolysin-deficient mutant of Actinobacillus pleuropneumoniae.

Authors:  A N Rycroft; D Williams; I A McCandlish; D J Taylor
Journal:  Vet Rec       Date:  1991-11-16       Impact factor: 2.695

7.  Comparison of the cytolysin II genetic determinants of Actinobacillus pleuropneumoniae serotypes.

Authors:  R Jansen; J Briaire; E M Kamp; M A Smits
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Characterization of the hemolysin transporter, HlyB, using an epitope insertion.

Authors:  P Juranka; F Zhang; J Kulpa; J Endicott; M Blight; I B Holland; V Ling
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

9.  Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies.

Authors:  E M Kamp; J K Popma; J Anakotta; M A Smits
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Haemolysin-derived synthetic peptides with pore-forming and haemolytic activity.

Authors:  R L Oropeza-Wekerle; S Muller; J P Briand; R Benz; A Schmid; W Goebel
Journal:  Mol Microbiol       Date:  1992-01       Impact factor: 3.501

View more
  7 in total

1.  Gene expression profile analysis of Porphyromonas gingivalis during invasion of human coronary artery endothelial cells.

Authors:  Paulo H Rodrigues; Ann Progulske-Fox
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae.

Authors:  E Maier; N Reinhard; R Benz; J Frey
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  First chromosomal restriction map of Actinobacillus pleuropneumoniae and localization of putative virulence-associated genes.

Authors:  W Oswald; D V Konine; J Rohde; G F Gerlach
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

4.  Growth of Actinobacillus pleuropneumoniae is promoted by exogenous hydroxamate and catechol siderophores.

Authors:  M S Diarra; J A Dolence; E K Dolence; I Darwish; M J Miller; F Malouin; M Jacques
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

5.  Comparative genomic characterization of Actinobacillus pleuropneumoniae.

Authors:  Zhuofei Xu; Xiabing Chen; Lu Li; Tingting Li; Shengyue Wang; Huanchun Chen; Rui Zhou
Journal:  J Bacteriol       Date:  2010-08-27       Impact factor: 3.490

6.  Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils.

Authors:  R Jansen; J Briaire; H E Smith; P Dom; F Haesebrouck; E M Kamp; A L Gielkens; M A Smits
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Genome biology of Actinobacillus pleuropneumoniae JL03, an isolate of serotype 3 prevalent in China.

Authors:  Zhuofei Xu; Yan Zhou; Liangjun Li; Rui Zhou; Shaobo Xiao; Yun Wan; Sihua Zhang; Kai Wang; Wei Li; Lu Li; Hui Jin; Mingsong Kang; Baolige Dalai; Tingting Li; Lei Liu; Yangyi Cheng; Lei Zhang; Tao Xu; Huajun Zheng; Shiying Pu; Bofei Wang; Wenyi Gu; Xiang-Lin Zhang; Geng-Feng Zhu; Shengyue Wang; Guo-Ping Zhao; Huanchun Chen
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.